Innate immunity evasion by enteroviruses: Insights into virus-host interaction

Viruses

Volumn 8, Issue 1, 2016, Pages

  Lei, Xiaobo ^a   Xiao, Xia ^a   Wang, Jianwei ^a,b  

^a INSTITUTE OF PATHOGEN BIOLOGY   (China)

^b ZHEJIANG UNIVERSITY   (China)

Author keywords

Antiviral response evasion; Enteroviruses; Innate immune responses; Pattern recognition receptors

Indexed keywords

CASPASE RECRUITMENT DOMAIN SIGNALING PROTEIN; CRYOPYRIN; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; INTERFERON; INTERFERON REGULATORY FACTOR 3; INTERFERON REGULATORY FACTOR 7; MYELOID DIFFERENTIATION FACTOR 88; NUCLEOTIDE BINDING OLIGOMERIZATION DOMAIN LIKE RECEPTOR; POLYADENYLIC ACID BINDING PROTEIN; RETINOIC ACID INDUCIBLE PROTEIN I; TOLL LIKE RECEPTOR 3; TOLL LIKE RECEPTOR 4; TOLL LIKE RECEPTOR 7; TOLL LIKE RECEPTOR 8; TOLL LIKE RECEPTOR 9; TOLL LIKE RECEPTOR ADAPTOR MOLECULE 1; TUMOR NECROSIS FACTOR RECEPTOR ASSOCIATED FACTOR 6; VIRUS PROTEIN;

ENTEROVIRUS INFECTION; HUMAN; IMMUNE EVASION; INNATE IMMUNITY; NONHUMAN; PROTEIN SYNTHESIS; REVIEW; SIGNAL TRANSDUCTION; VIRUS CELL INTERACTION; VIRUS DETECTION; VIRUS GENOME; VIRUS INTERFERENCE; VIRUS PATHOGENESIS; ANIMAL; ENTEROVIRUS; GENETICS; HOST PATHOGEN INTERACTION; IMMUNOLOGY; PHYSIOLOGY; VIROLOGY;

ANIMALS; ENTEROVIRUS; ENTEROVIRUS INFECTIONS; HOST-PATHOGEN INTERACTIONS; HUMANS; IMMUNE EVASION; IMMUNITY, INNATE;

EID: 84954408623     PISSN: None     EISSN: 19994915     Source Type: Journal    
DOI: 10.3390/v8010022     Document Type: Review

References (99)

1. The Pirbright Institute, UK. Available online: http://www.picornaviridae.com/enterovirus/enterovirus.htm (accessed on 10 October 2015).
2. Racaniello, V.R. Picornarviridae: The Viruses and Their Replication. In Fielda Virology; Howley, P.M., Knipe, D.M., Eds.; Lippincott Williams & Wilkins: Philadelphia, PA, USA, 2013.
3. Tebruegge, M.; Curtis, N. Enterovirus infections in neonates. Semin. Fetal Neonatal Med. 2009, 14, 222-227. [CrossRef] [PubMed]
4. Precechtelova, J.; Borsanyiova, M.; Sarmirova, S.; Bopegamage, S. Type I diabetes mellitus: Genetic factors and presumptive enteroviral etiology or protection. J. Pathog. 2014. [CrossRef] [PubMed]
5. Whitton, J.L.; Cornell, C.T.; Feuer, R. Host and virus determinants of picornavirus pathogenesis and tropism. Nat. Rev. Microbiol. 2005, 3, 765-776. [CrossRef] [PubMed]
6. Hammond, C.; Kurten, M.; Kennedy, J.L. Rhinovirus and asthma: A storied history of incompatibility. Curr. Allergy Asthma Rep. 2015, 15. [CrossRef] [PubMed]
7. Stone, C.A., Jr.; Miller, E.K. Understanding the association of human rhinovirus with asthma. Clin. Vaccine Immunol. 2015. [CrossRef] [PubMed]
8. Glanville, N.; Johnston, S.L. Challenges in developing a cross-serotype rhinovirus vaccine. Curr. Opin. Virol. 2015, 11, 83-88. [CrossRef] [PubMed]
9. Greninger, A.L.; Naccache, S.N.; Messacar, K.; Clayton, A.; Yu, G.; Somasekar, S.; Federman, S.; Stryke, D.; Anderson, C.; Yagi, S.; et al. A novel outbreak enterovirus D68 strain associated with acute flaccid myelitis cases in the USA (2012-2014): A retrospective cohort study. Lancet Infect. Dis. 2015, 15, 671-682. [CrossRef]
10. Khan, F. Enterovirus D68: Acute respiratory illness and the 2014 outbreak. Emerg. Med. Clin. North Am. 2015, 33, e19-e32. [CrossRef] [PubMed]
11. Waghmare, A.; Pergam, S.A.; Jerome, K.R.; Englund, J.A.; Boeckh, M.; Kuypers, J. Clinical disease due to enterovirus D68 in adult hematologic malignancy patients and hematopoietic cell transplant recipients. Blood 2015, 125, 1724-1729. [CrossRef] [PubMed]
12. Oberste, M.S.; Maher, K.; Schnurr, D.; Flemister, M.R.; Lovchik, J.C.; Peters, H.; Sessions, W.; Kirk, C.; Chatterjee, N.; Fuller, S.; et al. Enterovirus 68 is associated with respiratory illness and shares biological features with both the enteroviruses and the rhinoviruses. J. Gen. Virol. 2004, 85, 2577-2584. [CrossRef] [PubMed]
13. Puenpa, J.; Mauleekoonphairoj, J.; Linsuwanon, P.; Suwannakarn, K.; Chieochansin, T.; Korkong, S.; Theamboonlers, A.; Poovorawan, Y. Prevalence and characterization of enterovirus infections among pediatric patients with hand foot mouth disease, herpangina and influenza like illness in Thailand, 2012. PLoS ONE 2014, 9. [CrossRef]
14. Tapparel, C.; Siegrist, F.; Petty, T.J.; Kaiser, L. Picornavirus and enterovirus diversity with associated human diseases. Infect. Genet. Evol. 2013, 14, 282-293. [CrossRef] [PubMed]
15. Zhang, T.; Du, J.; Xue, Y.; Su, H.; Yang, F.; Jin, Q. Epidemics and frequent recombination within species in outbreaks of human enterovirusB-associated hand, foot and mouth disease in Shandong China in 2010 and 2011. PLoS ONE 2013, 8. [CrossRef]
16. Chan, K.P.; Goh, K.T.; Chong, C.Y.; Teo, E.S.; Lau, G.; Ling, A.E. Epidemic hand, foot and mouth disease caused by human enterovirus 71, Singapore. Emerg. Infect. Dis. 2003, 9, 78-85. [CrossRef] [PubMed]
17. McMinn, P.; Stratov, I.; Nagarajan, L.; Davis, S. Neurological manifestations of enterovirus 71 infection in children during an outbreak of hand, foot, and mouth disease inWestern Australia. Clin. Infect. Dis. 2001, 32, 236-242. [CrossRef] [PubMed]
18. Xing, W.; Liao, Q.; Viboud, C.; Zhang, J.; Sun, J.; Wu, J.T.; Chang, Z.; Liu, F.; Fang, V.J.; Zheng, Y.; et al. Hand, foot, and mouth disease in China, 2008-2012: An epidemiological study. Lancet Infect. Dis. 2014, 14, 308-318. [CrossRef]
19. Wang, S.M.; Lei, H.Y.; Yu, C.K.; Wang, J.R.; Su, I.J.; Liu, C.C. Acute chemokine response in the blood and cerebrospinal fluid of children with enterovirus 71-associated brainstem encephalitis. J. Infect. Dis. 2008, 198, 1002-1006. [CrossRef] [PubMed]
20. WHO. A Guide to Clinical Management and Public Health Response for Hand, Foot and Mouth Disease (HFMD); WHO: Geneva, Switzerland, 2011.
21. Yang, F.; Ren, L.; Xiong, Z.; Li, J.; Xiao, Y.; Zhao, R.; He, Y.; Bu, G.; Zhou, S.; Wang, J.; et al. Enterovirus 71 outbreak in the People's Republic of China in 2008. J. Clin. Microbiol. 2009, 47, 2351-2352. [CrossRef] [PubMed]
22. Centers for Disease Control and Prevention (CDC). Notes from the field: Severe hand, foot, and mouth disease associated with coxsackievirus A6-Alabama, Connecticut, California, and Nevada, November 2011-February 2012. MMWR Morb. Mortal. Weekly Rep. 2012, 61, 213-214.
23. Li, J.L.; Yuan, J.; Yang, F.; Wu, Z.Q.; Hu, Y.F.; Xue, Y.; Zhou, B.P.; Jin, Q. Epidemic characteristics of hand, foot, and mouth disease in southern China, 2013: Coxsackievirus A6 has emerged as the predominant causative agent. J. Infect. 2014, 69, 299-303. [CrossRef] [PubMed]
24. Osterback, R.; Vuorinen, T.; Linna, M.; Susi, P.; Hyypia, T.; Waris, M. Coxsackievirus A6 and hand, foot, and mouth disease, Finland. Emerg. Infect. Dis. 2009, 15, 1485-1488. [CrossRef] [PubMed]
25. Krausslich, H.G.; Nicklin, M.J.; Toyoda, H.; Etchison, D.; Wimmer, E. Poliovirus proteinase 2A induces cleavage of eucaryotic initiation factor 4F polypeptide p220. J. Virol. 1987, 61, 2711-2718. [PubMed]
26. Lei, X.; Liu, X.; Ma, Y.; Sun, Z.; Yang, Y.; Jin, Q.; He, B.; Wang, J. The 3C protein of enterovirus 71 inhibits retinoid acid-inducible gene I-mediated interferon regulatory factor 3 activation and type I interferon responses. J. Virol. 2010, 84, 8051-8061. [CrossRef] [PubMed]
27. Li, M.L.; Hsu, T.A.; Chen, T.C.; Chang, S.C.; Lee, J.C.; Chen, C.C.; Stollar, V.; Shih, S.R. The 3C protease activity of enterovirus 71 induces human neural cell apoptosis. Virology 2002, 293, 386-395. [CrossRef] [PubMed]
28. Wang, B.; Xi, X.; Lei, X.; Zhang, X.; Cui, S.;Wang, J.; Jin, Q.; Zhao, Z. Enterovirus 71 protease 2Apro targets MAVS to inhibit anti-viral type I interferon responses. PLoS Pathog. 2013, 9, e1003231. [CrossRef] [PubMed]
29. Weng, K.F.; Li, M.L.; Hung, C.T.; Shih, S.R. Enterovirus 71 3C protease cleaves a novel target CstF-64 and inhibits cellular polyadenylation. PLoS Pathog. 2009, 5. [CrossRef] [PubMed]
30. Devasthanam, A.S. Mechanisms underlying the inhibition of interferon signaling by viruses. Virulence 2014, 5, 270-277. [CrossRef] [PubMed]
31. Schneider, W.M.; Chevillotte, M.D.; Rich, C.M. Interferon-stimulated genes: A complex web of host defenses. Annu. Rev. Immunol. 2014, 32, 513-545. [CrossRef] [PubMed]
32. Kato, H.; Takeuchi, O.; Sato, S.; Yoneyama, M.; Yamamoto, M.; Matsui, K.; Uematsu, S.; Jung, A.; Kawai, T.; Ishii, K.J.; et al. Differential roles of MDA5 and RIG-I helicases in the recognition of RNA viruses. Nature 2006, 441, 101-105. [CrossRef] [PubMed]
33. Takeuchi, O.; Akira, S. Innate immunity to virus infection. Immunol. Rev. 2009, 227, 75-86. [CrossRef] [PubMed]
34. Yan, N.; Chen, Z.J. Intrinsic antiviral immunity. Nat. Immunol. 2012, 13, 214-222. [CrossRef] [PubMed]
35. Xagorari, A.; Chlichlia, K. Toll-like receptors and viruses: Induction of innate antiviral immune responses. Open Microbiol. J. 2008, 2, 49-59. [CrossRef] [PubMed]
36. Poltorak, A.; He, X.; Smirnova, I.; Liu, M.Y.; van Huffel, C.; Du, X.; Birdwell, D.; Alejos, E.; Silva, M.; Galanos, C.; et al. Defective LPS signaling in C3H/HeJ and C57BL/10ScCr mice: Mutations in Tlr4 gene. Science 1998, 282, 2085-2088. [CrossRef] [PubMed]
37. Takeda, K.; Akira, S. Toll-like receptors in innate immunity. Int. Immunol. 2005, 17, 1-14. [CrossRef] [PubMed]
38. Kawai, T.; Akira, S. Innate immune recognition of viral infection. Nat. Immunol. 2006, 7, 131-137. [CrossRef] [PubMed]
39. Jiang, Z.; Mak, T.W.; Sen, G.; Li, X. Toll-like receptor 3-mediated activation of NF-κB and IRF3 diverges at Toll-IL-1 receptor domain-containing adapter inducing IFN-β. Proc. Natl. Acad. Sci. USA 2004, 101, 3533-3538. [CrossRef] [PubMed]
40. Muroi, M.; Tanamoto, K. TRAF6 distinctively mediates MyD88- and IRAK-1-induced activation of NF-κB. J. Leukoc. Biol. 2008, 83, 702-707. [CrossRef] [PubMed]
41. 1-Triphosphate RNA is the ligand for RIG-I. Science 2006, 314, 994-997. [CrossRef] [PubMed]
42. Schuberth-Wagner, C.; Ludwig, J.; Bruder, A.K.; Herzner, A.M.; Zillinger, T.; Goldeck, M.; Schmidt, T.; Schmid-Burgk, J.L.; Kerber, R.; Wolter, S.; et al. A conserved histidinein the RNA sensor RIG-I controls immune tolerance to N1-2'O-methylated self RNA. Immunity 2015, 43, 41-51. [CrossRef] [PubMed]
43. Wilkins, C.; Gale, M., Jr. Recognition of viruses by cytoplasmic sensors. Curr. Opin. Immunol. 2010, 22, 41-47. [CrossRef] [PubMed]
44. Lamkanfi, M.; Dixit, V.M. Mechanisms and functions of inflammasomes. Cell 2014, 157, 1013-1022. [CrossRef] [PubMed]
45. Schroder, K.; Zhou, R.; Tschopp, J. The NLRP3 inflammasome: A sensor for metabolic danger? Science 2010, 327, 296-300. [CrossRef] [PubMed]
46. Keller, M.; Ruegg, A.; Werner, S.; Beer, H.D. Active caspase-1 is a regulator of unconventional protein secretion. Cell 2008, 132, 818-831. [CrossRef] [PubMed]
47. Lu, A.; Magupalli, V.G.; Ruan, J.; Yin, Q.; Atianand, M.K.; Vos, M.R.; Schroder, G.F.; Fitzgerald, K.A.; Wu, H.; Egelman, E.H. Unified polymerization mechanism for the assembly of ASC-dependent inflammasomes. Cell 2014, 156, 1193-1206. [CrossRef] [PubMed]
48. Triantafilou, K.; Orthopoulos, G.; Vakakis, E.; Ahmed, M.A.; Golenbock, D.T.; Lepper, P.M.; Triantafilou, M. Human cardiac inflammatory responses triggered by Coxsackie B viruses are mainly Toll-like receptor (TLR) 8-dependent. Cell Microbiol. 2005, 7, 1117-1126. [CrossRef] [PubMed]
49. Coyne, C.B.; Bozym, R.; Morosky, S.A.; Hanna, S.L.; Mukherjee, A.; Tudor, M.; Kim, K.S.; Cherry, S. Comparative RNAi screening reveals host factors involved in enterovirus infection of polarized endothelial monolayers. Cell Host Microbe 2011, 9, 70-82. [CrossRef] [PubMed]
50. Wang, J.P.; Asher, D.R.; Chan, M.; Kurt-Jones, E.A.; Finberg, R.W. Cutting Edge: Antibody-mediated TLR7-dependent recognition of viral RNA. J. Immunol. 2007, 178, 3363-3367. [CrossRef] [PubMed]
51. Richer, M.J.; Lavallee, D.J.; Shanina, I.; Horwitz, M.S. Toll-like receptor 3 signaling on macrophages is required for survival following coxsackievirus B4 infection. PLoS ONE 2009, 4, e4127. [CrossRef] [PubMed]
52. Abston, E.D.; Coronado, M.J.; Bucek, A.; Onyimba, J.A.; Brandt, J.E.; Frisancho, J.A.; Kim, E.; Bedja, D.; Sung, Y.K.; Radtke, A.J.; et al. TLR3 deficiency induces chronic inflammatory cardiomyopathy in resistant mice following coxsackievirusB3 infection: Role for IL-4. Am. J. Physiol. Regul. Integr. Comp. Physiol. 2013, 304, R267-R277. [CrossRef] [PubMed]
53. Negishi, H.; Osawa, T.; Ogami, K.; Ouyang, X.; Sakaguchi, S.; Koshiba, R.; Yanai, H.; Seko, Y.; Shitara, H.; Bishop, K.; et al. A critical link between Toll-like receptor 3 and type II interferon signaling pathways in antiviral innate immunity. Proc. Natl. Acad. Sci. USA 2008, 105, 20446-20451. [CrossRef] [PubMed]
54. Abe, Y.; Fujii, K.; Nagata, N.; Takeuchi, O.; Akira, S.; Oshiumi, H.; Matsumoto, M.; Seya, T.; Koike, S. The toll-like receptor 3-mediated antiviral response is important for protection against poliovirus infection in poliovirus receptor transgenic mice. J. Virol. 2012, 86, 185-194. [CrossRef] [PubMed]
55. Hsiao, H.B.; Chou, A.H.; Lin, S.I.; Chen, I.H.; Lien, S.P.; Liu, C.C.; Chong, P.; Liu, S.J. Toll-like receptor 9-mediated protection of enterovirus 71 infection in mice is due to the release of danger-associated molecular patterns. J. Virol. 2014, 88, 11658-11670. [CrossRef] [PubMed]
56. Feng, Q.; Langereis, M.A.; Lork, M.; Nguyen, M.; Hato, S.V.; Lanke, K.; Emdad, L.; Bhoopathi, P.; Fisher, P.B.; Lloyd, R.E.; et al. Enterovirus 2Apro targets MDA5 and MAVS in infected cells. J. Virol. 2014, 88, 3369-3378. [CrossRef] [PubMed]
57. Kuo, R.L.; Kao, L.T.; Lin, S.J.; Wang, R.Y.; Shih, S.R. MDA5 plays a crucial role in enterovirus 71 RNA-mediated IRF3 activation. PLoS ONE 2013, 8. [CrossRef] [PubMed]
58. Wang, J.P.; Cerny, A.; Asher, D.R.; Kurt-Jones, E.A.; Bronson, R.T.; Finberg, R.W. MDA5 and MAVS mediate type I interferon responses to coxsackie B virus. J. Virol. 2010, 84, 254-260. [CrossRef] [PubMed]
59. Feng, Q.; Hato, S.V.; Langereis, M.A.; Zoll, J.; Virgen-Slane, R.; Peisley, A.; Hur, S.; Semler, B.L.; van Rij, R.P.; van Kuppeveld, F.J. MDA5 detects the double-stranded RNA replicative form in picornavirus-infected cells. Cell Rep. 2012, 2, 1187-1196. [CrossRef] [PubMed]
60. Slater, L.; Bartlett, N.W.; Haas, J.J.; Zhu, J.; Message, S.D.; Walton, R.P.; Sykes, A.; Dahdaleh, S.; Clarke, D.L.; Belvisi, M.G.; et al. Co-ordinated role of TLR3, RIG-I and MDA5 in the innate response to rhinovirus in bronchial epithelium. PLoS Pathog. 2010, 6. [CrossRef] [PubMed]
61. Wang, Y.; Gao, B.; Xiong, S. Involvement of NLRP3 inflammasome in CVB3-induced viral myocarditis. Am. J. Physiol. Heart Circ. Physiol. 2014, 307, H1438-H1447. [CrossRef] [PubMed]
62. Wang, H.; Lei, X.; Xiao, X.; Yang, C.; Lu,W.; Huang, Z.; Leng, Q.; Jin, Q.; He, B.; Meng, G.; et al. Reciprocal regulation between enterovirus71 and the NLRP3 inflammasome. Cell Rep. 2015, 12, 42-48. [CrossRef] [PubMed]
63. Lloyd, R.E.; Grubman, M.J.; Ehrenfeld, E. Relationship of p220 cleavage during picornavirus infection to 2A proteinase sequencing. J. Virol. 1988, 62, 4216-4223. [PubMed]
64. Joachims, M.; van Breugel, P.C.; Lloyd, R.E. Cleavage of poly(A)-binding protein by enterovirus proteases concurrent with inhibition of translation in vitro. J. Virol. 1999, 73, 718-727. [PubMed]
65. Kerekatte, V.; Keiper, B.D.; Badorff, C.; Cai, A.; Knowlton, K.U.; Rhoads, R.E. Cleavage of Poly(A)-binding protein by coxsackievirus 2A protease in vitro and in vivo: Another mechanism for host protein synthesis shutoff? J. Virol. 1999, 73, 709-717. [PubMed]
66. Kuyumcu-Martinez, N.M.; van Eden, M.E.; Younan, P.; Lloyd, R.E. Cleavage of poly(A)-binding protein by poliovirus 3C protease inhibits host cell translation: A novel mechanism for host translation shutoff. Mol. Cell Biol. 2004, 24, 1779-1790. [CrossRef] [PubMed]
67. Clark, M.E.; Lieberman, P.M.; Berk, A.J.; Dasgupta, A. Direct cleavage of human TATA-binding protein by poliovirus protease 3C in vivo and in vitro. Mol. Cell Biol. 1993, 13, 1232-1237. [CrossRef] [PubMed]
68. Weidman, M.K.; Yalamanchili, P.; Ng, B.; Tsai,W.; Dasgupta, A. Poliovirus 3C protease-mediated degradation of transcriptional activator p53 requires a cellular activity. Virology 2001, 291, 260-271. [CrossRef] [PubMed]
69. Yalamanchili, P.; Harris, K.; Wimmer, E.; Dasgupta, A. Inhibition of basal transcription by poliovirus: A virus-Encodedprotease (3Cpro) inhibits formation of TBP-TATA box complex in vitro. J. Virol. 1996, 70, 2922-2929. [PubMed]
70. Barral, P.M.; Sarkar, D.; Fisher, P.B.; Racaniello, V.R. RIG-I is cleaved during picornavirus infection. Virology 2009, 391, 171-176. [CrossRef] [PubMed]
71. Barral, P.M.; Morrison, J.M.; Drahos, J.; Gupta, P.; Sarkar, D.; Fisher, P.B.; Racaniello, V.R. MDA-5 is cleaved in poliovirus-infected cells. J. Virol. 2007, 81, 3677-3684. [CrossRef] [PubMed]
72. Rebsamen, M.; Meylan, E.; Curran, J.; Tschopp, J. The antiviral adaptor proteins Cardif and Trif are processed and inactivated by caspases. Cell Death Differ. 2008, 15, 1804-1811. [CrossRef] [PubMed]
73. Mukherjee, A.; Morosky, S.A.; Delorme-Axford, E.; Dybdahl-Sissoko, N.; Oberste, M.S.;Wang, T.; Coyne, C.B. The coxsackievirus B 3C protease cleaves MAVS and TRIF to attenuate host type I interferon and apoptotic signaling. PLoS Pathog. 2011, 7. [CrossRef]
74. Drahos, J.; Racaniello, V.R. Cleavage of IPS-1 in cells infected with human rhinovirus. J. Virol. 2009, 83, 11581-11587. [CrossRef] [PubMed]
75. Lei, X.; Sun, Z.; Liu, X.; Jin, Q.; He, B.; Wang, J. Cleavage of the adaptor protein TRIF by enterovirus 71 3C inhibits antiviral responses mediated by Toll-like receptor 3. J. Virol. 2011, 85, 8811-8818. [CrossRef] [PubMed]
76. Xiang, Z.; Li, L.; Lei, X.; Zhou, H.; Zhou, Z.; He, B.; Wang, J. Enterovirus 68 3C protease cleaves TRIF to attenuate antiviral responses mediated by Toll-like receptor 3. J. Virol. 2014, 88, 6650-6659. [CrossRef] [PubMed]
77. Lei, X.; Xiao, X.; Xue, Q.; Jin, Q.; He, B.; Wang, J. Cleavage of interferon regulatory factor 7 by enterovirus 71 3C suppresses cellular responses. J. Virol. 2013, 87, 1690-1698. [CrossRef] [PubMed]
78. Xiang, Z.; Liu, L.; Lei, X.; Zhou, Z.; He, B.;Wang, J. The 3C protease of enterovirusD68 inhibits the cellular defense mediated by interferon regulatory factor 7. J. Virol. 2015. [CrossRef] [PubMed]
79. Hung, H.C.;Wang, H.C.; Shih, S.R.; Teng, I.F.; Tseng, C.P.; Hsu, J.T. Synergistic inhibition of enterovirus 71 replication by interferon and rupintrivir. J. Infect. Dis. 2011, 203, 1784-1790. [CrossRef] [PubMed]
80. Zheng, Z.; Li, H.; Zhang, Z.; Meng, J.; Mao, D.; Bai, B.; Lu, B.; Mao, P.; Hu, Q.; Wang, H. Enterovirus 71 2C protein inhibits TNF-β-mediated activation of NF-κB by suppressing IκB kinase β phosphorylation. J. Immunol. 2011, 187, 2202-2212. [CrossRef] [PubMed]
81. Du, H.; Yin, P.; Yang, X.; Zhang, L.; Jin, Q.; Zhu, G. Enterovirus 71 2C Protein Inhibits NF-κB Activation by Binding to RelA(p65). Sci. Rep. 2015, 5. [CrossRef] [PubMed]
82. Lei, X.; Han, N.; Xiao, X.; Jin, Q.; He, B.; Wang, J. Enterovirus 71 3C inhibits cytokine expression through cleavage of the TAK1/TAB1/TAB2/TAB3 complex. J. Virol. 2014, 88, 9830-9841. [CrossRef] [PubMed]
83. Lu, J.; Yi, L.; Zhao, J.; Yu, J.; Chen, Y.; Lin, M.C.; Kung, H.F.; He, M.L. Enterovirus 71 disrupts interferon signaling by reducing the level of interferon receptor 1. J. Virol. 2012, 86, 3767-3776. [CrossRef] [PubMed]
84. Fung, G.; Ng, C.S.; Zhang, J.; Shi, J.; Wong, J.; Piesik, P.; Han, L.; Chu, F.; Jagdeo, J.; Jan, E.; et al. Production of a dominant-negative fragment due to G3BP1 cleavage contributes to the disruption of mitochondria-associated protective stress granules during CVB3 infection. PLoS ONE 2013, 8, e79546. [CrossRef] [PubMed]
85. Ho, B.C.; Yu, I.S.; Lu, L.F.; Rudensky, A.; Chen, H.Y.; Tsai, C.W.; Chang, Y.L.; Wu, C.T.; Chang, L.Y.; Shih, S.R.; et al. Inhibition of miR-146a prevents enterovirus-induced death by restoring the production of type I interferon. Nat. Commun. 2014, 5. [CrossRef] [PubMed]
86. Xu, C.; He, X.; Zheng, Z.; Zhang, Z.; Wei, C.; Guan, K.; Hou, L.; Zhang, B.; Zhu, L.; Cao, Y.; et al. Downregulation of microRNA miR-526a by enterovirus inhibits RIG-I-dependent innate immune response. J. Virol. 2014, 88, 11356-11368. [CrossRef] [PubMed]
87. Yang, J.; Yang, C.; Guo, N.; Zhu, K.; Luo, K.; Zhang, N.; Zhao, H.; Cui, Y.; Chen, L.;Wang, H.; et al. Type I interferons triggered through the Toll-like receptor 3-TRIF pathway control coxsackievirusA16 infection in young mice. J. Virol. 2015, 89, 10860-10867. [CrossRef] [PubMed]
88. Zhu, K.; Yang, J.; Luo, K.; Yang, C.; Zhang, N.; Xu, R.; Chen, J.; Jin, M.; Xu, B.; Guo, N.; et al. TLR3 signaling in macrophages is indispensable for the protective immunity of invariant natural killer T cells against enterovirus 71 infection. PLoS Pathog. 2015, 11. [CrossRef] [PubMed]
89. Lee, Y.P.; Wang, Y.F.; Wang, J.R.; Huang, S.W.; Yu, C.K. Enterovirus 71 blocks selectively type I interferon production through the 3C viral protein in mice. J. Med. Virol. 2012, 84, 1779-1789. [CrossRef] [PubMed]
90. Liu, Y.; Zhang, Z.; Zhao, X.; Yu, R.; Zhang, X.; Wu, S.; Liu, J.; Chi, X.; Song, X.; Fu, L.; et al. Enterovirus 71 inhibits cellular type I interferon signaling by downregulating JAK1 protein expression. Viral Immunol. 2014, 27, 267-276. [CrossRef] [PubMed]
91. Fitzgerald, K.D.; Semler, B.L. Poliovirus infection induces the co-localization of cellular protein SRp20 with TIA-1, a cytoplasmic stress granule protein. Virus Res. 2013, 176, 223-231. [CrossRef] [PubMed]
92. Onomoto, K.; Yoneyama, M.; Fung, G.; Kato, H.; Fujita, T. Antiviral innate immunity and stress granule responses. Trends Immunol. 2014, 35, 420-428. [CrossRef] [PubMed]
93. Reineke, L.C.; Lloyd, R.E. The stress granule protein G3BP1 recruits protein kinase R to promote multiple innate immune antiviral responses. J. Virol. 2015, 89, 2575-2589. [CrossRef] [PubMed]
94. White, J.P.; Cardenas, A.M.; Marissen, W.E.; Lloyd, R.E. Inhibition of cytoplasmic mRNA stress granule formation by a viral proteinase. Cell Host Microbe 2007, 2, 295-305. [CrossRef] [PubMed]
95. Cui, L.; Guo, X.; Qi, Y.; Qi, X.; Ge, Y.; Shi, Z.; Wu, T.; Shan, J.; Shan, Y.; Zhu, Z.; et al. Identification of microRNAs involved in the host response to enterovirus 71 infection by a deep sequencing approach. J. Biomed. Biotechnol. 2010, 2010. [CrossRef] [PubMed]
96. Cui, L.; Qi, Y.; Li, H.; Ge, Y.; Zhao, K.; Qi, X.; Guo, X.; Shi, Z.; Zhou, M.; Zhu, B.; et al. Serum microRNA expression profile distinguishes enterovirus 71 and coxsackievirus 16 infections in patients with hand-foot-and-mouth disease. PLoS ONE 2011, 6, e27071. [CrossRef] [PubMed]
97. Wu, J.; Shen, L.; Chen, J.; Xu, H.; Mao, L. The role of microRNAs in enteroviral infections. Braz. J. Infect. Dis. 2015, 19, 510-516. [CrossRef] [PubMed]
98. Ida-Hosonuma, M.; Iwasaki, T.; Yoshikawa, T.; Nagata, N.; Sato, Y.; Sata, T.; Yoneyama, M.; Fujita, T.; Taya, C.; Yonekawa, H.; et al. The α/β interferon response controls tissue tropism and pathogenicity of poliovirus. J. Virol. 2005, 79, 4460-4469. [CrossRef] [PubMed]
99. Liu, M.L.; Lee, Y.P.; Wang, Y.F.; Lei, H.Y.; Liu, C.C.; Wang, S.M.; Su, I.J.; Wang, J.R.; Yeh, T.M.; Chen, S.H.; et al. Type I interferons protect mice against enterovirus 71 infection. J. Gen. Virol. 2005, 86, 3263-3269. [CrossRef] [PubMed]